XML 45 R39.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Financial Statement Details - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Accrued compensation $ 8,606 $ 2,832
Accrued research and development expenses 12,084 14,453
Accrued contract termination costs 3,149 2,767
Other accrued expenses 4,755 9,920
Total accrued expenses $ 28,594 $ 29,972 [1]
[1] All share and per share amounts have been retrospectively adjusted to reflect a one-for-fifteen reverse stock split (see Note 6).